Azenta, Inc. (AZTA)

NASDAQ: AZTA · IEX Real-Time Price · USD
56.90
+0.50 (0.89%)
Jan 27, 2023, 4:00 PM EST - Market closed

Company Description

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally.

The company operates through two reportable segments, Life Sciences Products and Life Sciences Services.

The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows.

The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development.

This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services.

It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes.

The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021.

Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Azenta, Inc.
Azenta logo
Country United States
Founded 1978
IPO Date Feb 1, 1995
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 3,200
CEO Stephen Schwartz

Contact Details

Address:
200 Summit Drive, 6th Floor
Burlington, Massachusetts 01803
United States
Phone (978) 262-2400
Website azenta.com

Stock Details

Ticker Symbol AZTA
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0000933974
CUSIP Number 114340102
ISIN Number US1143401024
Employer ID 04-3040660
SIC Code 3559

Key Executives

Name Position
Dr. Stephen S. Schwartz Chief Executive Officer, President and Director
Lindon G. Robertson Executive Vice President and Chief Financial Officer
Robin Vacha Senior Vice President of Global Operations
Michael Paulo Vice President and Chief Information and Digital Officer
Sara Silverman Head of Investor Relations
Jason W. Joseph Senior Vice President, General Counsel and Corporate Secretary
John E. O'Brien Senior Vice President of Corporate Development
Claribel Purcell Senior Vice President of Global Sales
Kimberly Crowley Senior Vice President and Chief Human Resources Officer
J. Robert Woodward Senior Vice President of Global Quality and Regulatory

Latest SEC Filings

Date Type Title
Jan 10, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 6, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Dec 21, 2022 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Dec 21, 2022 DEF 14A Other definitive proxy statements
Dec 15, 2022 8-K/A [Amend] Current report
Nov 25, 2022 10-K Annual Report
Nov 23, 2022 8-K Current Report
Nov 14, 2022 8-K Current Report
Oct 17, 2022 8-K Current Report
Oct 7, 2022 8-K Current Report